The similarities and differences in European Union (EU) and United States (US) animal welfare laws and policies for research and safety assessment are debated.

SEURAT tests xCELLigence from Roche

Monday, 02 April 2012 09:41

The xCELLigence RTCA System from Roche has been tested by the EU initiative SEURAT ("Safety Evaluation Ultimately Replacing Animal Testing"), which runs from 2011 until 2016, as an alternative to animal testing in the cosmetics industry.

This workshop presented and organized by Vittorio Prodi, member of the European Parliament and ENVI and ITRE committees, will be held at the European Parliament in Brussels on 15 May 2012 from 12:00 to 14:00 in Room PHS 1A002.

cellasys GmbH: BioChip datasheets available

Saturday, 31 March 2012 09:43

The cellasys GmbH, a spin-out of the Technische Universität München, published detailed description of their micro-sensor-chips for investigation of living cells. For the first time, now the pin configuration is available to the public.

According to the motto "Its time for a research without animal experiments" on 24 april a panel discussion takes place in the Berlin Urania.

In order to facilitate the interpretion of the huge, continously increasing data amount on Parkinson´s scientists of the Berlin Max-Planck Institute of Molecular Genetics in collaboration with 44 international partners from around the world have developed a comprehensive free accessible data compendium about the Parkinsons´ disease.

The Center for Alternatives to Animal Testing (CAAT) located in the United States and at Constance University in Germany arranged a forum to inform and discuss the results of Expert workshops from March 20th through 21st, 2012.  The forum dealt with the realization of the strategic plan for closing gaps in research on animal-free systemic toxicity testing.

The workshop and congress Biological Barriers on 29th February to 9th March 2012 at Saarland University was held under the titel „Biological Barriers – in vitro and in silico Tools for Drug Delivery and Nanosafety Research“ for the ninth time.

Today test methods for immunological medicinal products are based on animal experiments. With the help of the 3R concept (replacement, reduction and refinement) application and suffering of animals in experiments required by law can be reduced or avoided completely.

The German Federal Institute of Drugs and Medical Devices (BfArM) has approved an animal-free procedure for testing of Allergan´s botulinum products.